HYDRASYS 2 SCAN FOCUSING is the “all-in-one” analyzer for gel electrophoresis. The system offers analytical solutions for a high level of performance, matching clinical diagnostic requirements.
The analyzer carries out electrophoresis steps, from sample application to final reading. It is a fast and easy to operate instrument, offering a comprehensive test menu of more than 60 HYDRAGEL programs.
HYDRASYS 2 SCAN FOCUSING when coupled with the ASSIST is designed to accomodate all workflow requirements; by automating sample preparation to ensure standardization and traceability.
Have confidence when reporting your patients’ results with best-in-class gel electrophoresis assays.
Ability to migrate, stain, & scan gels on one system.
PHORESIS Core Software provides tools for interpretation, data & result management and networking.
Automation and standardization of samples preparation with ASSIST.
Sample types: Serum, urine, plasma CSF, whole blood
Throughput (tests/hour)
Proteinuria screening for renal disease.
Identification of monoclonal proteins by agarose gel electrophoresis.
The gold standard assay for the alpha 1-antitrypsin (A1AT) phenotype testing.
The gold standard assay to detect CNS local IgG synthesis in multiple sclerosis.
The high-resolution method for hemoglobin disorders screening.
Understand your needs and constraints to provide you with the most suitable and integrated solution.
Educational Webinar with Prof. Alessandro Gozzetti, MD, PhD
Learn how a Sebia customer utilized our Workflow Service offering and CAPILLARYS 3 instruments to achieved higher throughput and improved workflow.
Sebia specializes in providing testing solutions for a range of diseases, including Diabetes and Multiple Myeloma. Learn about the impact of these diseases and the medical solutions available.
Learn more about the HYDRASYS 2 SCAN FOCUSING for a fast and user-friendly gel electrophoresis processing.
The HYDRASHIFT portfolio include IVD test to mitigate interferences seen in immunofixation result for patient treated with daratumumab.
Pitfalls and caveats in α1-antitrypsin deficiency testing: a guide for clinicians.
2005 Multiple sclerosis consensus criteria includes CSF IgG oligoclonal bands.
2017 Mc Donald Criteria for multiple sclerosis diagnosis includes CSF IgG oligoclonal bands.
Evaluation of Sebia’s isoelectrofocusing kit for A1AT with HYDRASYS.
Immunotherapies for Multiple Myeloma, like the monoclonal antibody daratumumab, can create false positive IgG Kappa bands on Immunofixation gels. This paper describes best practice guidelines for using the Hydrashift assay to remove daratumumab interference from Immunofixation gels.
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country.
Please contact your local Sebia representative. Information intended for healthcare professionals.
Carefully read the instructions in the reagent package inserts and instrument manuals.